No results for ‘’
Hindustan Bio Sciences Ltd
NSE: BSE: 532041
₹8.04
(1.52%)
Mon, 21 Sept 2026, 09:04 pm
Market Cap (in Cr)8.24
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
2001
- The Company entered into an agreement with CDSL, NSDL and Venture Capital & Corporate Investments Ltd for dematerialisation.
2004
- Hindustan Bio bagged GEAC nod for recombinant human erythropoietin.
2005
- Hindustan Bio Sciences Ltd received an order for Antiretroviral drug for a value of Rs 269.30 million from China.